Title:
【発明の名称】心臓病のための新規ターゲット遺伝子
Document Type and Number:
Japanese Patent JP2003534809
Kind Code:
A
Abstract:
The present invention relates to a variety of genes abnormally expressed in heart tissue as well as to fragments of such genes. Assessment of the expression level of these genes may be used for testing the predisposition of mammals and preferably humans for a heart disease or for an acute state of such a disease. Preferred diseases in accordance with the invention are congestive heart failure, dilative cardiomyopathy, hypertrophic cardiomyopathy and ischemic cardiomyopathy. The present invention further relates to methods of identifying compounds capable of normalizing the expression level of the aforementioned genes and of further genes affected by the abnormal expression. The identified compounds may be used for formulating compositions, preferably pharmaceutical compositions for preventing or treating diseases. They may also be used as lead compounds for the development of medicaments having an improved efficiency, a longer half-life, a decreased toxicity etc. and to be employed in the treatment of heart diseases. Included in the invention are also somatic gene therapy methods comprising the introduction of at least one functional copy of any of the above-mentioned genes into a suitable cell. Finally, the invention relates to non-human transgenic animals comprising at least one of the aforementioned genes in their germ line. The transgenic animals of the invention may be used for the development of medicaments for the treatment of heart diseases.
More Like This:
Inventors:
Bunk Danilla
Roynel Birgit
Beck Joachim
Henkel Thomas
Roynel Birgit
Beck Joachim
Henkel Thomas
Application Number:
JP2002500758A
Publication Date:
November 25, 2003
Filing Date:
May 30, 2001
Export Citation:
Assignee:
Medijan Akchen Gezel Shaft
International Classes:
A01K67/027; A61K38/00; A61K45/00; A61K48/00; A61P9/00; A61P9/02; A61P9/04; A61P9/10; A61P9/12; C07K14/47; C12N15/09; C12N15/85; C12Q1/50; C12Q1/68; C12Q1/6883; G01N33/15; G01N33/50; G01N33/53; G01N33/566; (IPC1-7): C12Q1/68; A01K67/027; A61K38/00; A61K45/00; A61K48/00; A61P9/00; A61P9/02; A61P9/04; A61P9/10; A61P9/12; C12Q1/50; G01N33/15; G01N33/50; G01N33/53; G01N33/566
Attorney, Agent or Firm:
Patent Service Corporation Patent Office Sykes
Previous Patent: 酵素を用いるＲ−体又はＳ−体のα−置換ヘテロサイクリックカルボン酸...
Next Patent: マイコバクテリウム種識別及び薬剤耐性探知のための診断キット並びにそ...
Next Patent: マイコバクテリウム種識別及び薬剤耐性探知のための診断キット並びにそ...